Expert Q&A: Labs Must Take a Greater Role in Guiding Clinicians About Abnormal Data
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.
While ChatGPT has its place, allowing lab staff to use it exposes you to liabilities—here are some ways to manage the risks involved.
As generative AI chatbot use increases, labs may want to implement a written acceptable use policy for staff.
These three lab testing areas were the main sources of fraud and abuse revealed in the OIG’s latest Semi-Annual Report to Congress.
Congress is renewing its previous efforts to make Medicare reimbursement of pharmacy testing permanent—here’s what that could mean for labs.
According to a recent report, Medicare overpaid for such services over a two-year period between 2019 and 2020.
Current genetic testing enforcement trends and what you can do to minimize the liability risks of your lab.
After it failed to pass at the end of 2022, lab leaders and other insiders say they’re optimistic SALSA will pass this year.
Gather Labs founder and CEO Rachael McCrary discusses how her lab has achieved success beyond COVID-19 testing.
Recent survey provides insight into how current pressures are impacting laboratory staff wages and compensation.